Cerus
About:
Cerus is a biomedical products company focused in the field of blood safety.
Website: http://www.cerus.com/
Top Investors: Oxford Finance LLC
Description:
Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development.
$236M
$100M to $500M
Concord, California, United States
1991-09-01
B.J. Cassin, Laurence M. Corash, Stephen T. Isaacs
251-500
2020-01-28
Public
© 2025 bioDAO.ai